43 related articles for article (PubMed ID: 30085332)
1. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
Wang Y; Yang L; Zhang J; Zhou M; Shen L; Deng W; Liang L; Hu R; Yang W; Yao Y; Zhang H; Zhang Z
Int J Oncol; 2018 Oct; 53(4):1667-1680. PubMed ID: 30085332
[TBL] [Abstract][Full Text] [Related]
2. Zerumbone increases oxidative stress in a thiol-dependent ROS-independent manner to increase DNA damage and sensitize colorectal cancer cells to radiation.
Deorukhkar A; Ahuja N; Mercado AL; Diagaradjane P; Raju U; Patel N; Mohindra P; Diep N; Guha S; Krishnan S
Cancer Med; 2015 Feb; 4(2):278-92. PubMed ID: 25450478
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the c-myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses.
Qian J; Zhang Z; Han X; Zhu L; Bian Z; Xie T
Biomed Res Int; 2022; 2022():1948657. PubMed ID: 35141331
[TBL] [Abstract][Full Text] [Related]
4. CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.
Prevo R; Pirovano G; Puliyadi R; Herbert KJ; Rodriguez-Berriguete G; O'Docherty A; Greaves W; McKenna WG; Higgins GS
Cell Cycle; 2018; 17(12):1513-1523. PubMed ID: 30045664
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal Cancer Therapy via Synthetic Lethality with ATR Inhibitors.
Liu TT; Wang Q; Zhou Y; Ye B; Liu T; Yan L; Fan J; Xu J; Zhou Y; Xia Z; Deng X
J Med Chem; 2024 May; 67(9):7620-7634. PubMed ID: 38634707
[TBL] [Abstract][Full Text] [Related]
6. Oligomycin A promotes radioresistance in HT29 colorectal cancer cells and its mechanisms.
Li X; Tian R; Wang L; Xu C; Wu H; Liu L; Huang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 46(2):113-120. PubMed ID: 33678646
[TBL] [Abstract][Full Text] [Related]
7. Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation.
Xu Y; Lai H; Pan S; Pan L; Liu T; Yang Z; Chen T; Zhu X
Biomaterials; 2024 Mar; 305():122452. PubMed ID: 38154440
[TBL] [Abstract][Full Text] [Related]
8. Examination of Hypoxanthine Guanine Phosphoribosyltransferase as a biomarker for colorectal cancer patients.
Townsend MH; Felsted AM; Burrup W; Robison RA; O'Neill KL
Mol Cell Oncol; 2018; 5(4):e1481810. PubMed ID: 30250925
[TBL] [Abstract][Full Text] [Related]
9. Furanocoumarin compounds isolated from
Pengnam S; Jitkaroon W; Srisuphan R; Wongprayoon P; Rayanil KO; Charoensuksai P
Acta Pharm; 2024 Mar; 74(1):67-79. PubMed ID: 38554381
[TBL] [Abstract][Full Text] [Related]
10. Roles of B7-H3 in Cervical Cancer and Its Prognostic Value.
Han S; Shi X; Liu L; Zong L; Zhang J; Chen Q; Qian Q; Chen L; Wang Y; Jin J; Ma Y; Cui B; Yang X; Zhang Y
J Cancer; 2018; 9(15):2612-2624. PubMed ID: 30087701
[TBL] [Abstract][Full Text] [Related]
11. Knockdown Of TRIM31 Enhances Colorectal Cancer Radiosensitivity By Inducing DNA Damage And Activating Apoptosis.
Zhang H; Deng Y; Liang L; Shen L; Zhu J; Wang Y; Zhang J; Zhang Z
Onco Targets Ther; 2019; 12():8179-8188. PubMed ID: 31632068
[TBL] [Abstract][Full Text] [Related]
12. The impact of target dosimetry on patients' locoregional recurrence in nasopharyngeal carcinoma: A propensity score-matched analysis.
Wang J; Qing G; Ou X; Hu W; Hu C; Zhang Z
Radiother Oncol; 2019 Dec; 141():67-71. PubMed ID: 31547944
[TBL] [Abstract][Full Text] [Related]
13. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.
Jain SM; Nagainallur Ravichandran S; Murali Kumar M; Banerjee A; Sun-Zhang A; Zhang H; Pathak R; Sun XF; Pathak S
Cancer Biol Ther; 2024 Dec; 25(1):2317999. PubMed ID: 38445632
[TBL] [Abstract][Full Text] [Related]
14. 6-
Yang KH; Yen CY; Wang SC; Chang FR; Chang MY; Chan CK; Jeng JH; Tang JY; Chang HW
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398060
[TBL] [Abstract][Full Text] [Related]
15. Targeting key RNA methylation enzymes to improve the outcome of colorectal cancer chemotherapy (Review).
Shao C; Han Y; Huang Y; Zhang Z; Gong T; Zhang Y; Tian X; Fang M; Han X; Li M
Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38131226
[TBL] [Abstract][Full Text] [Related]
16. Double-strand DNA break repair: molecular mechanisms and therapeutic targets.
Tan J; Sun X; Zhao H; Guan H; Gao S; Zhou PK
MedComm (2020); 2023 Oct; 4(5):e388. PubMed ID: 37808268
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing Effects of Irinotecan versus Oxaliplatin Alone and in Combination with 5-Fluorouracil on Human Colorectal Cancer Cells.
Frerker B; Bock F; Cappel ML; Kriesen S; Klautke G; Hildebrandt G; Manda K
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373535
[TBL] [Abstract][Full Text] [Related]
18. A specific dispiropiperazine derivative that arrests cell cycle, induces apoptosis, necrosis and DNA damage.
Liu VP; Li WM; Lofroth J; Zeb M; Patrick BO; Bott TM; Lee CH
Sci Rep; 2023 May; 13(1):8674. PubMed ID: 37248333
[TBL] [Abstract][Full Text] [Related]
19. Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice.
Park W; O'Connor CA; Bandlamudi C; Forman D; Chou JF; Umeda S; Reyngold M; Varghese AM; Keane F; Balogun F; Yu KH; Kelsen DP; Crane C; Capanu M; Iacobuzio-Donahue C; O'Reilly EM
Clin Cancer Res; 2022 Nov; 28(21):4782-4792. PubMed ID: 36040493
[TBL] [Abstract][Full Text] [Related]
20. Effects of Radiotherapy in Combination With Irinotecan and 17-AAG on Bcl-2 and Caspase 3 Gene Expression in Colorectal Cancer Cells.
Ebrahimpour M; Mohammadian M; Pourheydar B; Moradi Z; Behrouzkia Z
J Lasers Med Sci; 2022; 13():e9. PubMed ID: 35996484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
